Application of Artificial Intelligence in Drug Discovery

Area of Science:

• Computational chemistry
• Bioinformatics
• Pharmacology

Background:

• Modern drug discovery is increasingly reliant on big data analytics.
• Pharmaceutical companies are actively integrating AI to accelerate the identification of novel drug candidates.
• The vast volume of datasets necessitates advanced computational approaches for efficient analysis.

Approach:

• Artificial intelligence (AI) algorithms are employed to analyze large datasets, predict molecular structures, and forecast compound characteristics.
• Machine learning models assist in understanding in-vivo vs. in-vitro properties, reducing the need for extensive experimental testing.
• Data mining and curation techniques enable rapid exploration and extraction of valuable insights from complex biological and chemical data.

Key Points:

• AI enables precise prediction of molecular structures and their properties, minimizing trial-and-error.
• The integration of clinical studies, electronic health records, and imaging data enhances AI-driven drug development.
• AI tools and software streamline the drug discovery pipeline, from initial research to optimization.

Conclusions:

• AI is revolutionizing rational drug development by leveraging big data for more knowledgeable and efficient processes.
• The adoption of AI in pharmaceutical research promises significant time and economic savings.
• This review highlights key advancements in AI, software, and tools that facilitate the drug discovery journey.